The Manufacturers Life Insurance Company Purchases 9,156 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

The Manufacturers Life Insurance Company boosted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 14.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,943 shares of the company’s stock after purchasing an additional 9,156 shares during the period. The Manufacturers Life Insurance Company’s holdings in LifeStance Health Group were worth $363,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of LifeStance Health Group by 17.6% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 184,190 shares of the company’s stock valued at $1,136,000 after acquiring an additional 27,605 shares in the last quarter. Jennison Associates LLC boosted its stake in shares of LifeStance Health Group by 0.7% in the first quarter. Jennison Associates LLC now owns 1,938,323 shares of the company’s stock valued at $11,959,000 after buying an additional 12,629 shares during the period. GSA Capital Partners LLP raised its position in LifeStance Health Group by 161.6% during the first quarter. GSA Capital Partners LLP now owns 69,492 shares of the company’s stock valued at $429,000 after purchasing an additional 42,932 shares in the last quarter. SG Americas Securities LLC raised its position in LifeStance Health Group by 8.7% during the first quarter. SG Americas Securities LLC now owns 44,925 shares of the company’s stock valued at $277,000 after purchasing an additional 3,600 shares in the last quarter. Finally, Allen Investment Management LLC acquired a new position in LifeStance Health Group during the first quarter valued at approximately $79,000. Institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

Shares of LifeStance Health Group stock opened at $7.21 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $9.20. The stock has a market cap of $2.76 billion, a price-to-earnings ratio of -15.02 and a beta of 1.24. The company’s fifty day moving average is $6.58 and its 200 day moving average is $6.09.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. LifeStance Health Group had a negative net margin of 13.05% and a negative return on equity of 10.51%. The company had revenue of $312.30 million for the quarter, compared to analysts’ expectations of $305.85 million. During the same quarter in the previous year, the firm posted ($0.13) earnings per share. LifeStance Health Group’s revenue for the quarter was up 20.3% on a year-over-year basis. Sell-side analysts forecast that LifeStance Health Group, Inc. will post -0.24 EPS for the current year.

Analyst Ratings Changes

LFST has been the subject of several research analyst reports. UBS Group lowered their price objective on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research report on Thursday, August 15th. Barclays lowered their price target on shares of LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a report on Friday, August 9th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $8.25.

Insider Buying and Selling at LifeStance Health Group

In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $6.28, for a total transaction of $33,089.32. Following the sale, the insider now owns 263,007 shares of the company’s stock, valued at approximately $1,651,683.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 6.60% of the company’s stock.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.